Results 181 to 190 of about 11,305,394 (400)

Global variation in copy number in the human genome

open access: yesNature, 2006
R. Redon   +49 more
semanticscholar   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype

open access: yesNature Biotechnology, 2019
Daehwan Kim   +4 more
semanticscholar   +1 more source

Long-read human genome sequencing and its applications

open access: yesNature reviews genetics, 2020
Glennis A. Logsdon   +2 more
semanticscholar   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

open access: yesMolecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone   +11 more
wiley   +1 more source

Systematic discovery of regulatory motifs in conserved regions of the human genome, including thousands of CTCF insulator sites

open access: green, 2007
Xiaohui Xie   +5 more
openalex   +1 more source

High-Resolution Profiling of Histone Methylations in the Human Genome

open access: yesCell, 2007
A. Barski   +8 more
semanticscholar   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

O09: Phenome-wide studies of hereditary transthyretin amyloidosis in the All of Us research program

open access: yesGenetics in Medicine Open
Cassia Williams-Rogers   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy